Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Single-Cell Analysis | 12 | 2024 | 146 | 4.570 |
Why?
|
| NF-kappa B | 10 | 2023 | 465 | 3.780 |
Why?
|
| Microfluidics | 9 | 2023 | 52 | 3.160 |
Why?
|
| Cell Culture Techniques | 8 | 2020 | 192 | 2.410 |
Why?
|
| Microfluidic Analytical Techniques | 9 | 2017 | 45 | 2.310 |
Why?
|
| Signal Transduction | 13 | 2023 | 3373 | 2.180 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2024 | 481 | 1.610 |
Why?
|
| Organoids | 2 | 2022 | 62 | 1.540 |
Why?
|
| Cell Communication | 2 | 2024 | 199 | 1.410 |
Why?
|
| Cytokines | 6 | 2023 | 802 | 1.230 |
Why?
|
| Lab-On-A-Chip Devices | 5 | 2019 | 23 | 1.220 |
Why?
|
| Antiviral Agents | 6 | 2024 | 475 | 1.200 |
Why?
|
| Lipopolysaccharides | 4 | 2017 | 293 | 1.190 |
Why?
|
| RNA, Messenger | 6 | 2022 | 2011 | 1.120 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2019 | 299 | 1.110 |
Why?
|
| High-Throughput Screening Assays | 2 | 2020 | 58 | 1.040 |
Why?
|
| Proteins | 2 | 2022 | 786 | 1.000 |
Why?
|
| Herpesvirus 1, Human | 3 | 2024 | 244 | 0.940 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2021 | 699 | 0.920 |
Why?
|
| Fibroblasts | 3 | 2015 | 755 | 0.920 |
Why?
|
| Proteomics | 2 | 2024 | 230 | 0.870 |
Why?
|
| 3T3 Cells | 7 | 2021 | 97 | 0.830 |
Why?
|
| Cellular Microenvironment | 2 | 2019 | 29 | 0.820 |
Why?
|
| Biosensing Techniques | 1 | 2023 | 73 | 0.810 |
Why?
|
| Animals | 27 | 2024 | 27317 | 0.800 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 207 | 0.790 |
Why?
|
| Formaldehyde | 1 | 2021 | 52 | 0.780 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2022 | 35 | 0.780 |
Why?
|
| Gene Expression Regulation | 7 | 2022 | 1975 | 0.760 |
Why?
|
| Cell Tracking | 2 | 2018 | 14 | 0.760 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2020 | 78 | 0.730 |
Why?
|
| Polymers | 1 | 2021 | 194 | 0.720 |
Why?
|
| Bacteriological Techniques | 1 | 2020 | 39 | 0.710 |
Why?
|
| Mice | 18 | 2022 | 11737 | 0.710 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2020 | 75 | 0.700 |
Why?
|
| Proteome | 1 | 2021 | 132 | 0.690 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 232 | 0.690 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2017 | 91 | 0.680 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2018 | 15 | 0.650 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 58 | 0.640 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 594 | 0.640 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2018 | 11 | 0.640 |
Why?
|
| Polymerase Chain Reaction | 2 | 2022 | 921 | 0.620 |
Why?
|
| Host-Pathogen Interactions | 2 | 2022 | 236 | 0.610 |
Why?
|
| Chemotaxis | 2 | 2016 | 73 | 0.580 |
Why?
|
| Lipopeptides | 1 | 2017 | 17 | 0.580 |
Why?
|
| Chemokine CCL19 | 1 | 2016 | 10 | 0.570 |
Why?
|
| Chemokine CCL21 | 1 | 2016 | 16 | 0.570 |
Why?
|
| Gene Expression Profiling | 5 | 2022 | 1429 | 0.550 |
Why?
|
| Transcriptome | 1 | 2021 | 628 | 0.550 |
Why?
|
| Basigin | 1 | 2016 | 5 | 0.540 |
Why?
|
| Macrophages | 3 | 2017 | 571 | 0.540 |
Why?
|
| Bacteria | 1 | 2020 | 472 | 0.540 |
Why?
|
| Cells | 1 | 2016 | 32 | 0.530 |
Why?
|
| Salmonella typhimurium | 1 | 2015 | 32 | 0.520 |
Why?
|
| Paracrine Communication | 1 | 2015 | 32 | 0.500 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 1157 | 0.470 |
Why?
|
| Allergy and Immunology | 1 | 2014 | 13 | 0.470 |
Why?
|
| Systems Biology | 1 | 2014 | 44 | 0.460 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 504 | 0.440 |
Why?
|
| Dendritic Cells | 1 | 2016 | 442 | 0.430 |
Why?
|
| Cell Line | 7 | 2024 | 2495 | 0.430 |
Why?
|
| Autoimmunity | 1 | 2014 | 168 | 0.420 |
Why?
|
| Cell Differentiation | 1 | 2019 | 1521 | 0.420 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 308 | 0.410 |
Why?
|
| NIH 3T3 Cells | 3 | 2019 | 110 | 0.410 |
Why?
|
| Cysteine Proteinase Inhibitors | 2 | 2021 | 53 | 0.390 |
Why?
|
| Herpes Simplex | 2 | 2024 | 203 | 0.370 |
Why?
|
| Time-Lapse Imaging | 3 | 2019 | 20 | 0.360 |
Why?
|
| Virus Replication | 5 | 2024 | 321 | 0.340 |
Why?
|
| Coculture Techniques | 2 | 2023 | 173 | 0.330 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 2411 | 0.330 |
Why?
|
| HEK293 Cells | 3 | 2021 | 638 | 0.320 |
Why?
|
| Humans | 23 | 2024 | 89063 | 0.310 |
Why?
|
| Cells, Cultured | 4 | 2018 | 2880 | 0.300 |
Why?
|
| Automation | 2 | 2020 | 111 | 0.300 |
Why?
|
| A549 Cells | 3 | 2022 | 41 | 0.300 |
Why?
|
| Vero Cells | 3 | 2024 | 102 | 0.280 |
Why?
|
| Cell Nucleus | 3 | 2023 | 599 | 0.260 |
Why?
|
| Benzamides | 2 | 2023 | 237 | 0.250 |
Why?
|
| Piperidines | 2 | 2023 | 164 | 0.250 |
Why?
|
| Coronavirus OC43, Human | 2 | 2021 | 7 | 0.250 |
Why?
|
| Drug Repositioning | 1 | 2024 | 23 | 0.240 |
Why?
|
| Computational Biology | 2 | 2021 | 542 | 0.240 |
Why?
|
| Drug Discovery | 2 | 2022 | 107 | 0.240 |
Why?
|
| Microscopy, Fluorescence | 3 | 2017 | 428 | 0.240 |
Why?
|
| Thiazoles | 2 | 2023 | 128 | 0.240 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2021 | 887 | 0.240 |
Why?
|
| Acyclovir | 1 | 2024 | 108 | 0.230 |
Why?
|
| Pyridines | 2 | 2023 | 315 | 0.230 |
Why?
|
| Genome, Viral | 1 | 2023 | 80 | 0.220 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2021 | 42 | 0.220 |
Why?
|
| Substrate Specificity | 2 | 2016 | 352 | 0.220 |
Why?
|
| DNA, Viral | 1 | 2023 | 261 | 0.210 |
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 1 | 2022 | 10 | 0.210 |
Why?
|
| Stochastic Processes | 2 | 2015 | 77 | 0.210 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2022 | 91 | 0.210 |
Why?
|
| Cannabidiol | 1 | 2022 | 7 | 0.210 |
Why?
|
| Protein Interaction Mapping | 1 | 2022 | 82 | 0.200 |
Why?
|
| Cloud Computing | 1 | 2021 | 11 | 0.190 |
Why?
|
| Oligonucleotides | 1 | 2022 | 92 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 3209 | 0.180 |
Why?
|
| Saliva | 1 | 2021 | 123 | 0.180 |
Why?
|
| Mass Spectrometry | 1 | 2021 | 193 | 0.180 |
Why?
|
| User-Computer Interface | 1 | 2021 | 187 | 0.180 |
Why?
|
| Neoplasm Metastasis | 1 | 2024 | 1108 | 0.180 |
Why?
|
| Mutation | 2 | 2023 | 4132 | 0.170 |
Why?
|
| Fluorescein-5-isothiocyanate | 2 | 2016 | 26 | 0.170 |
Why?
|
| Limit of Detection | 1 | 2019 | 20 | 0.170 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2752 | 0.170 |
Why?
|
| Intravital Microscopy | 1 | 2019 | 11 | 0.170 |
Why?
|
| Flow Cytometry | 1 | 2021 | 691 | 0.170 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 2552 | 0.170 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 242 | 0.170 |
Why?
|
| Colon | 1 | 2022 | 509 | 0.170 |
Why?
|
| Cell Survival | 2 | 2013 | 982 | 0.170 |
Why?
|
| Jurkat Cells | 1 | 2019 | 77 | 0.170 |
Why?
|
| Shock, Septic | 1 | 2020 | 104 | 0.170 |
Why?
|
| Neoplasms | 1 | 2014 | 3035 | 0.160 |
Why?
|
| Gene Dosage | 1 | 2019 | 208 | 0.160 |
Why?
|
| Tissue Array Analysis | 1 | 2018 | 127 | 0.160 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 43 | 0.160 |
Why?
|
| Immunity, Innate | 1 | 2022 | 429 | 0.160 |
Why?
|
| Computer Simulation | 1 | 2022 | 1097 | 0.150 |
Why?
|
| Genes, Reporter | 1 | 2018 | 275 | 0.150 |
Why?
|
| Immunoassay | 1 | 2017 | 91 | 0.150 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2017 | 6 | 0.150 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 309 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 387 | 0.150 |
Why?
|
| beta Catenin | 1 | 2019 | 266 | 0.150 |
Why?
|
| RNA | 1 | 2021 | 578 | 0.150 |
Why?
|
| Cell Cycle | 1 | 2019 | 509 | 0.140 |
Why?
|
| Cell Adhesion | 1 | 2018 | 426 | 0.140 |
Why?
|
| Photobleaching | 1 | 2016 | 8 | 0.140 |
Why?
|
| Immobilized Proteins | 1 | 2016 | 14 | 0.140 |
Why?
|
| Models, Biological | 2 | 2016 | 1763 | 0.140 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2017 | 202 | 0.130 |
Why?
|
| Clone Cells | 1 | 2016 | 214 | 0.130 |
Why?
|
| Cell Movement | 2 | 2016 | 783 | 0.130 |
Why?
|
| Cell Separation | 1 | 2016 | 198 | 0.130 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 262 | 0.130 |
Why?
|
| Bacterial Infections | 1 | 2017 | 184 | 0.130 |
Why?
|
| Acoustics | 1 | 2015 | 51 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 666 | 0.120 |
Why?
|
| Spectrum Analysis | 1 | 2015 | 119 | 0.120 |
Why?
|
| Portraits as Topic | 1 | 2014 | 6 | 0.120 |
Why?
|
| Time Factors | 2 | 2015 | 5320 | 0.120 |
Why?
|
| Transcription Factor RelA | 1 | 2013 | 49 | 0.110 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2013 | 67 | 0.110 |
Why?
|
| Diffusion | 1 | 2013 | 93 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2015 | 491 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2017 | 551 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2015 | 443 | 0.100 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2022 | 85 | 0.100 |
Why?
|
| Transcription Factors | 2 | 2022 | 1652 | 0.100 |
Why?
|
| Interferons | 2 | 2022 | 124 | 0.100 |
Why?
|
| Endoribonucleases | 2 | 2022 | 92 | 0.100 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2021 | 149 | 0.090 |
Why?
|
| Viral Load | 2 | 2021 | 145 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 3000 | 0.090 |
Why?
|
| Mice, Knockout | 1 | 2015 | 1990 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2010 | 78 | 0.090 |
Why?
|
| Software | 1 | 2014 | 665 | 0.090 |
Why?
|
| Equipment Design | 2 | 2017 | 415 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1940 | 0.070 |
Why?
|
| Drug Resistance, Viral | 1 | 2024 | 48 | 0.060 |
Why?
|
| Serial Passage | 1 | 2023 | 3 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2024 | 306 | 0.060 |
Why?
|
| Keratinocytes | 1 | 2024 | 146 | 0.060 |
Why?
|
| Eukaryotic Cells | 1 | 2023 | 44 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2023 | 73 | 0.060 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2022 | 16 | 0.050 |
Why?
|
| Inositol | 1 | 2022 | 15 | 0.050 |
Why?
|
| Ribonucleases | 1 | 2022 | 93 | 0.050 |
Why?
|
| Ligands | 1 | 2023 | 443 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2022 | 39 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2021 | 64 | 0.050 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2021 | 39 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2021 | 156 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2022 | 301 | 0.050 |
Why?
|
| Drug Design | 1 | 2021 | 125 | 0.050 |
Why?
|
| Bacterial Load | 1 | 2020 | 18 | 0.050 |
Why?
|
| beta-Lactam Resistance | 1 | 2020 | 11 | 0.050 |
Why?
|
| Gram-Negative Bacteria | 1 | 2020 | 35 | 0.040 |
Why?
|
| Gram-Positive Bacteria | 1 | 2020 | 18 | 0.040 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2020 | 35 | 0.040 |
Why?
|
| Decision Trees | 1 | 2020 | 59 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2021 | 314 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 282 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 126 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 2020 | 198 | 0.040 |
Why?
|
| Male | 2 | 2021 | 42251 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2020 | 261 | 0.040 |
Why?
|
| Machine Learning | 1 | 2021 | 257 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2017 | 16 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2022 | 688 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 1574 | 0.040 |
Why?
|
| Lung | 1 | 2022 | 1258 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 243 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1855 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2014 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1837 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2015 | 38 | 0.030 |
Why?
|
| Female | 3 | 2024 | 46011 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2015 | 45 | 0.030 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2013 | 15 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2013 | 54 | 0.030 |
Why?
|
| Interleukin-1 | 1 | 2013 | 72 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 2013 | 88 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 1755 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 170 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 3773 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2013 | 698 | 0.030 |
Why?
|
| Asthma | 1 | 2020 | 976 | 0.030 |
Why?
|
| Risk Factors | 1 | 2021 | 5466 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 1241 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1716 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 25863 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 26507 | 0.010 |
Why?
|